Piperidine derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S201000

Reexamination Certificate

active

07834032

ABSTRACT:
Compounds of the formula (I), in which R1, R2, Q, X, Y, m and n have the meanings indicated in Claim (1), are potent 5-HT2Aantagonists and are suitable for the treatment of psychoses, schizophrenia, depression, neurological disorders, memory disorders, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, Huntington's disease, eating disorders, such as bulimia, anorexia nervosa, of premenstrual syndrome and/or for positively influencing obsessive-compulsive disorder (OCD).

REFERENCES:
patent: 6815456 (2004-11-01), Zhou et al.
patent: 0208235 (1987-01-01), None
patent: 0319962 (1989-06-01), None
patent: 0320983 (1989-06-01), None
patent: 0337136 (1989-10-01), None
patent: WO 95/24194 (1995-09-01), None
patent: WO 99/11641 (1999-03-01), None
patent: WO 99/46245 (1999-09-01), None
patent: WO 02/44168 (2002-06-01), None
Suddon “Pseudopolymorph . . . ” Crystal growth & design 4(6) p. 1087 (2004) (two page from internet).
Brga et al. “making crystals . . . ” Chem. Commun. p. 3635-3645 (2005).
Kim et al. “new serotonin 5HT6 . . . ” CA148:92237 (2007).
Ramakrishna et al. “Substituted indolyl . . . ” CA150:329617 (2009).
Sobri et al. “Radiosynthesis . . . ” Bioorg. med. Chem. v.8, p. 2511-2518 (2000).
Smith et al. “Solid phase synthesisi . . . ” Bioorg. Med. Chem. Lett. v.10, p. 2693-2696 (2000).
Wikipedia “Antipsychotic” p. 1-11 (2009).
Awadallah “Synthesis pharmacophore . . . ” Sci. Pharm. v.76, p. 415-438 (2008).
Stiefl et al. “ErG:2D pharmacophore . . . ” J. chem. Inf. Model. v.46 p. 208-220 (2006).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Piperidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4175379

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.